Last year, the World Health Organization (WHO) issued its first guideline endorsing GLP-1 therapies for the long-term treatment of obesity, recognizing it as a chronic disease and recommending these agents as part of comprehensive management strategies that include diet, physical activity, and structured care
For a GLP-1 boost we want to target fermentable fiber
Revisiting the role of TRP, Orai, and ASIC channels in the pulmonary arterial response to hypoxia
Your doctor might suggest: Eating more fruits and vegetables Cutting back on sugary and fatty foods Doing 150 minutes of exercise each week Getting enough sleep Managing stress Long-term Use of Tirzepatide Tirzepatide is meant for long-term use in weight management
Vitamin C may help by acidifying urine, creating a less hospitable environment for bacterial growth
Nausea, for example, was reported by 18% to 22% of tirzepatide users (depending on the dose) compared to 18% of semaglutide users